Aia Group LTD Edwards Lifesciences Corp Transaction History

Aia Group LTD

$5.07 Billion
Q3 2025

A detailed history of Aia Group LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Aia Group LTD holds 308,225 shares of EW stock, worth $26.6 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

308,225

Previous 622,913 50.52%

Holding current value

$26.6 Million

Previous $48.7 Million 50.8%

% of portfolio

0.47%

Previous 1.15%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Dec 18, 2025	SELL	$73.75 - $81.83 $23.2 Million - $25.8 Million	-314,688 Reduced 50.52%	308,225 $24 Million
Q2 2025 Aug 06, 2025	SELL	$67.07 - $78.22 $2.86 Million - $3.34 Million	-42,665 Reduced 6.41%	622,913 $48.7 Million
Q1 2025 May 12, 2025	SELL	$67.95 - $76.19 $18 Million - $20.2 Million	-265,355 Reduced 28.5%	665,578 $48.2 Million
Q4 2024 Feb 12, 2025	BUY	$64.54 - $75.92 $11.7 Million - $13.8 Million	181,409 Added 24.2%	930,933 $68.9 Million
Q3 2024 Oct 31, 2024	BUY	$59.7 - $93.78 $21.4 Million - $33.6 Million	358,556 Added 91.71%	749,524 $49.5 Million

Q2 2024 Jul 31, 2024	SELL	$84.3 - $94.31 $8.6 Million - $9.62 Million	-102,001 Reduced 20.69%	390,968 $36.1 Million
Q1 2024 May 06, 2024	SELL	$72.54 - $95.56 $7.89 Million - $10.4 Million	-108,776 Reduced 18.08%	492,969 $47.1 Million
Q4 2023 Jan 31, 2024	BUY	$61.71 - $77.76 $8.3 Million - $10.5 Million	134,452 Added 28.77%	601,745 $45.9 Million
Q3 2023 Nov 01, 2023	BUY	$69.28 - $93.38 $5.29 Million - $7.13 Million	76,319 Added 19.52%	467,293 $32.4 Million
Q2 2023 Jul 28, 2023	SELL	$81.41 - $94.33 $5.88 Million - $6.81 Million	-72,237 Reduced 15.59%	390,974 $36.9 Million
Q1 2023 Apr 28, 2023	BUY	$74.26 - $84.51 $17 Million - $19.3 Million	228,272 Added 97.16%	463,211 $38.3 Million
Q4 2022 Jan 31, 2023	BUY	$68.3 - $87.44 $1.72 Million - $2.2 Million	25,131 Added 11.98%	234,939 $17.5 Million
Q3 2022 Nov 04, 2022	BUY	$82.37 - $107.29 $16.2 Million - $21.1 Million	196,330 Added 1456.67%	209,808 $17.3 Million
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $329,565 - $488,708	-3,810 Reduced 22.04%	13,478 $1.28 Million
Q1 2022 May 06, 2022	SELL	$101.96 - $128.34 $189,033 - $237,942	-1,854 Reduced 9.69%	17,288 $2.04 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $1.55 Million - $1.91 Million	14,582 Added 319.78%	19,142 $2.48 Million
Q3 2021 Nov 05, 2021	BUY	$102.91 - $122.75 $78,417 - $93,535	762 Added 20.06%	4,560 $516,000
Q2 2021 Aug 03, 2021	BUY	$83.84 - $104.76 $318,424 - $397,878	3,798 New	3,798 $391,000

Others Institutions Holding EW

# of Institutions

1,460

Shares Held

468M

Call Options Held

3.46M

Put Options Held

4.07M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aia Group LTD with notifications on news.

Account